Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Prime Medicine
Biotech
BMS pays Prime $110M to form T-cell therapy pact
Prime, which could receive $3.5 billion in milestones, disclosed the deal alongside prioritizations intended to extend its cash runway into 2026.
Nick Paul Taylor
Sep 30, 2024 7:18am
New prime editor delivery particles help restore vision in mice
Jan 9, 2024 7:00am
Prime's prime editors fix liver disease mutation in primates
Oct 30, 2023 11:47am
ASGCT 2023: New preclinical updates from Tessera, Tune and more
May 23, 2023 10:00am
Gene editing biotech Prime turns up the heat with $175M IPO
Oct 20, 2022 12:05pm
2 gene editing biotechs team up to improve on delivery
Mar 31, 2022 12:59pm
